Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Identification of blood microRNAs associated to Parkinsonĭs disease.

Margis R, Margis R, Rieder CR.

J Biotechnol. 2011 Mar 20;152(3):96-101. doi: 10.1016/j.jbiotec.2011.01.023. Epub 2011 Feb 3.

2.

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.

Miñones-Moyano E, Porta S, Escaramís G, Rabionet R, Iraola S, Kagerbauer B, Espinosa-Parrilla Y, Ferrer I, Estivill X, Martí E.

Hum Mol Genet. 2011 Aug 1;20(15):3067-78. doi: 10.1093/hmg/ddr210. Epub 2011 May 10.

PMID:
21558425
3.

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.

Botta-Orfila T, Morató X, Compta Y, Lozano JJ, Falgàs N, Valldeoriola F, Pont-Sunyer C, Vilas D, Mengual L, Fernández M, Molinuevo JL, Antonell A, Martí MJ, Fernández-Santiago R, Ezquerra M.

J Neurosci Res. 2014 Aug;92(8):1071-7. doi: 10.1002/jnr.23377. Epub 2014 Mar 20.

PMID:
24648008
4.

Analysis of the Micro-RNA-133 and PITX3 genes in Parkinson's disease.

de Mena L, Coto E, Cardo LF, Díaz M, Blázquez M, Ribacoba R, Salvador C, Pastor P, Samaranch L, Moris G, Menéndez M, Corao AI, Alvarez V.

Am J Med Genet B Neuropsychiatr Genet. 2010 Sep;153B(6):1234-9. doi: 10.1002/ajmg.b.31086.

PMID:
20468068
5.

Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.

Khoo SK, Petillo D, Kang UJ, Resau JH, Berryhill B, Linder J, Forsgren L, Neuman LA, Tan AC.

J Parkinsons Dis. 2012;2(4):321-31. doi: 10.3233/JPD-012144.

PMID:
23938262
6.

miRNA expression is highly sensitive to a drug therapy in Parkinson's disease.

Alieva AKh, Filatova EV, Karabanov AV, Illarioshkin SN, Limborska SA, Shadrina MI, Slominsky PA.

Parkinsonism Relat Disord. 2015 Jan;21(1):72-4. doi: 10.1016/j.parkreldis.2014.10.018. Epub 2014 Oct 27.

PMID:
25465742
7.

Serum miR-221 serves as a biomarker for Parkinson's disease.

Ma W, Li Y, Wang C, Xu F, Wang M, Liu Y.

Cell Biochem Funct. 2016 Oct;34(7):511-515. doi: 10.1002/cbf.3224.

PMID:
27748571
8.

Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.

Zhao N, Jin L, Fei G, Zheng Z, Zhong C.

Parkinsonism Relat Disord. 2014 Nov;20(11):1177-80. doi: 10.1016/j.parkreldis.2014.08.016. Epub 2014 Sep 1.

PMID:
25218846
9.

A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.

Dong H, Wang C, Lu S, Yu C, Huang L, Feng W, Xu H, Chen X, Zen K, Yan Q, Liu W, Zhang C, Zhang CY.

Biomarkers. 2016;21(2):129-37. doi: 10.3109/1354750X.2015.1118544. Epub 2015 Dec 3.

PMID:
26631297
10.

FGF20 rs12720208 SNP and microRNA-433 variation: no association with Parkinson's disease in Spanish patients.

de Mena L, Cardo LF, Coto E, Miar A, Díaz M, Corao AI, Alonso B, Ribacoba R, Salvador C, Menéndez M, Morís G, Alvarez V.

Neurosci Lett. 2010 Jul 19;479(1):22-5. doi: 10.1016/j.neulet.2010.05.019. Epub 2010 May 13.

PMID:
20471450
11.

Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.

Li N, Pan X, Zhang J, Ma A, Yang S, Ma J, Xie A.

Neurol Sci. 2017 May;38(5):761-767. doi: 10.1007/s10072-017-2841-9. Epub 2017 Feb 8.

PMID:
28181066
12.

Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma.

Li LM, Hu ZB, Zhou ZX, Chen X, Liu FY, Zhang JF, Shen HB, Zhang CY, Zen K.

Cancer Res. 2010 Dec 1;70(23):9798-807. doi: 10.1158/0008-5472.CAN-10-1001. Epub 2010 Nov 23. Erratum in: Cancer Res. 2011 Mar 1;71(5):2022.

13.

Differential expression of miRNAs in the visceral adipose tissue of patients with non-alcoholic fatty liver disease.

Estep M, Armistead D, Hossain N, Elarainy H, Goodman Z, Baranova A, Chandhoke V, Younossi ZM.

Aliment Pharmacol Ther. 2010 Aug;32(3):487-97. doi: 10.1111/j.1365-2036.2010.04366.x. Epub 2010 May 22.

14.

Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.

Dyrskjøt L, Ostenfeld MS, Bramsen JB, Silahtaroglu AN, Lamy P, Ramanathan R, Fristrup N, Jensen JL, Andersen CL, Zieger K, Kauppinen S, Ulhøi BP, Kjems J, Borre M, Orntoft TF.

Cancer Res. 2009 Jun 1;69(11):4851-60. doi: 10.1158/0008-5472.CAN-08-4043.

15.

Identification of a new microRNA expression profile as a potential cancer screening tool.

Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, Nijjar T, Scrimger R, Yee D, Xing J.

Clin Invest Med. 2010 Apr 1;33(2):E124.

PMID:
20370992
16.

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

Fulci V, Colombo T, Chiaretti S, Messina M, Citarella F, Tavolaro S, Guarini A, Foà R, Macino G.

Genes Chromosomes Cancer. 2009 Dec;48(12):1069-82. doi: 10.1002/gcc.20709.

PMID:
19760605
17.

Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.

Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, Zhang C, Tran N, Fan H, Retzlaff K, Bittner A, Raponi M.

BMC Cancer. 2009 Oct 20;9:374. doi: 10.1186/1471-2407-9-374.

18.

CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis.

Guled M, Lahti L, Lindholm PM, Salmenkivi K, Bagwan I, Nicholson AG, Knuutila S.

Genes Chromosomes Cancer. 2009 Jul;48(7):615-23. doi: 10.1002/gcc.20669.

PMID:
19396864
19.

microRNA expression profiling of nasopharyngeal carcinoma.

Li T, Chen JX, Fu XP, Yang S, Zhang Z, Chen KhH, Li Y.

Oncol Rep. 2011 May;25(5):1353-63. doi: 10.3892/or.2011.1204. Epub 2011 Mar 3.

PMID:
21373758
20.

Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer.

Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H.

J Clin Oncol. 2010 Apr 1;28(10):1721-6. doi: 10.1200/JCO.2009.24.9342. Epub 2010 Mar 1.

PMID:
20194856

Supplemental Content

Support Center